Objective: Low levels of selenium have been associated with a higher risk of cardiovascular diseases and cancer in humans. Since 1984, selenium supplementation through fertilizers has been employed in Finland to increase the very low concentration of selenium in the nation's food supply. As a result, the selenium concentration of Finnish foods became one of the highest in Europe. A decade after selenium supplementation began, the association between toenail selenium and the risk of breast cancer was examined. Design: Case-control study. Setting: Eastern Finland. Subjects: 289 pre-and postmenopausal breast cancer cases and 433 community controls. The diagnosis was unknown at the time the toenail samples were collected. Results: The mean toenail selenium concentration was 0.80 mgakg in premenopausal cases and 0.84 mgakg in premenopausal controls: and 0.77 mgakg in postmenopausal cases and 0.80 mgakg in postmenopausal controls. The odds ratio (OR) comparing the highest with the lowest quintiles of toenail selenium concentration was 1.1 (95% CI 0.4 ± 3.2) in premenopausal women and 0.7 (95% CI 0.3 ± 1.5) in postmenopausal women. The intake of retinol, beta-carotene, vitamin E and vitamin C did not change the association between toenail selenium and breast cancer. Conclusions: A decade after selenium supplementation, selenium seems not to be an important factor in the etiology of breast cancer, neither in premenopausal nor postmenopausal women.
Introduction
The selenium content of foods varies geographically depending on the amount of available selenium in soil. In Finland, the selenium content of soils is low and insuf®-ciently available to plants due to low temperatures combined with the soil's high humidity, low pH and high iron content (Aro et al, 1998) . Before the 1980s the selenium intake of the Finnish population was one of the lowest in international comparisons (25 ± 30 mgad). That was much lower than the recommended daily allowance of the US National Research Council (55 ± 70 mgad for adults) (National Research Council, 1989) .
When low serum selenium concentrations (`45 mgal) were shown to be associated with an increased risk of cardiovascular diseases and cancer in some Finnish cohort studies (Salonen et al, 1982 (Salonen et al, , 1985 , the Finnish Ministry of Agriculture and Forestry decided in 1984 to supplement all commercial fertilizers with selenium (Aro et al, 1998) . The nationwide supplementation program was effective in raising the selenium levels in the food supply. The mean intake of selenium is currently about 80 mgad, which is among the highest in Europe, but not as high as in the United States and Canada (over 100 mgad in most areas) (Alfthan & Neve, 1996) .
Early geographical comparisons have demonstrated remarkably high inverse correlations between selenium intake per capita and cancer mortality rates, especially for breast and colon cancer (Schrauzer et al, 1977) . A recent geographic study from the United States con®rmed the earlier ®ndings that a low selenium status increased the risk of cancer mortality, including breast cancer (Clark et al, 1991) . The ®ndings of epidemiological studies, however, are generally con¯icting. In particular, prospective studies in the Netherlands, where the selenium intake is moderate (toenail selenium 0.57 mgakg) (van den Brandt et al, 1994) , and in the United States, where the concentration is higher (0.82 mgakg) (Hunter et al, 1990) , have indicated no association between selenium and breast cancer risk. Therefore, it has been suggested that selenium is associated with the risk of cancer only at very low selenium levels. In a Finnish cohort study, in which serum selenium samples were collected between 1968 and 1972 (prior to supplementation), the relative risk of breast cancer between the four higher quintiles and the lowest quintile of serum selenium was 0.52 (90 breast cancer cases), but the result was not statistically signi®cant (Knekt et al, 1990) .
In this study we examined the association between toenail selenium concentration and the risk of breast cancer in a case-control study during 1990 ± 1995, 6 to 10 years after the beginning of the selenium supplementation of fertilizers. We also examined possible interactions between toenail selenium and the intake of retinol, betacarotene, vitamin E and vitamin C. The data were analyzed separately for premenopausal and postmenopausal women because it has been suggested that the etiology of breast cancer differs between younger and older women.
Subjects and methods
The subjects were participants in the Kuopio Breast Cancer Study, a case-control study that follows the protocol of the International Multicenter Study on Breast and Colorectal Cancer coordinated by the European Institute of Oncology in Milan. All women living in the catchment area of Kuopio University Hospital who were referred to an examination for suspected breast disease between 1990 and 1995 were invited to participate in the study. Only 12 of the cases refused to participate. When breast cancer was diagnosed, a population control was selected randomly from the National Population Register covering the same catchment area (ruralaurban) and matched for age ( AE 5 y) to the case. Exclusions due to an unwillingness to participate, an inability to cooperate, the presence of another serious disease, or a missing or unacceptable food frequency questionnaire have been presented earlier, as well as the summary of selected characteristics (for example age, residence, education and family history of breast cancer) of the study population (Ma Ènnisto È et al, 1999) . The ®nal participation rate of the controls was 72%. Additionally, 21 cases and 21 controls in this study were excluded for technical reasons (no toenail sample or insuf®cient size of toenail sample (n 35), or extremely high ( b 3 s.d.) selenium concentration considered to originate from external sources other than food (n 7)). The extremely high selenium concentration of toenails is usually due to contamination by selenium-rich shampoo, an effect which cannot be isolated in analyses. The ®nal selenium study comprised 289 breast cancer cases (112 premenopausal and 177 postmenopausal cases) and 433 population controls (168 premenopausal and 265 postmenopausal controls) within the age range of 25 ± 75 y. Classical risk factors for breast cancer were similar in this study compared to earlier ®ndings; late ®rst full-term pregnancy, low number of births, family history of breast cancer, and a history of benign breast disease increased the risk of breast cancer (Ma Ènnisto È et al, 1996a) . Approval for this study was given by the Joint Ethics Committee of Kuopio Universitya Kuopio University Hospital, and all subjects gave their written consent.
A validated semiquantitative food frequency questionnaire, which contains 110 food items and mixed dishes, was mailed with a letter inviting the subjects to attend an examination at the Kuopio University Hospital (Ma Ènnisto È et al, 1996b) . The subjects were asked to complete the questionnaire at home, describing their habitual diet over the previous 12 months. The questionnaire also allowed the use of dietary supplements to be recorded: brand name, occasionalaregular use, amount per day, week or month.
The questionnaire was checked by the study nurse during the hospital visit. During that interview body mass index (BMI) and waist-to-hip ratio (WHR) were also measured, and a questionnaire on background variables was interviewed including questions on socioeconomic status, medical history, family history of breast cancer, reproductive factors, physical activity, smoking and current alcohol consumption. Average daily intake of retinol, beta-carotene, vitamin E and vitamin C and supplement intakes were calculated using the Finnish Food Composition Database maintained at the National Public Health Institute. Only regular supplement use was addressed in the analyses.
Toenail selenium concentration was used instead of dietary selenium intake because the correlation between toenail selenium and dietary selenium was only 0.12 in our validation study (Ma Ènnisto È et al, 1996b) . The previous studies also give support for our decision that toenail selenium is a better measure of exposure than dietary assessment (Ovaskainen et al, 1993) . Further, toenail selenium is one of the best biomarkers for selenium, providing an estimate over six months to a year (Longnecker et al, 1993) , whereas dietary methods often do not measure selenium intake from food items accurately due to the widely varying selenium content of food samples.
An envelope for collection of the nail clippings was mailed to the participants along with a referral to an examination. The subjects were asked to wash their feet carefully and cut nail clippings of all toes. The envelope was returned to the study nurse during the interview at the hospital. At that time the diagnosis was still unknown since the subjects followed the normal hospital examinations after this interview. The toenail selenium analyses were carried out by the Department of Nutrition at the National Public Health Institute. The nail samples were cleaned with 1% sodium dodecylsulphate for 1 h. After 1 minute of ultrasonication, the samples were rinsed thoroughly with demineralized water and dried. The selenium concentration of the samples was analyzed by acid-digestion¯uorimetry using 2.3 ± diaminonaphthalene to produce the piaselenole (Alfthan, 1984) . A standard reference material (BCR, Bovine Liver 185, Community Bureau of References, Brussels) was analyzed in each series (n 23), the mean AE s.d. value being 0.47 AE 0.01 mgakg compared with the certi®ed value of 0.47 AE 0.01 mgakg. The laboratory personnel were blind to the case-control status of the samples.
Statistical methods
The logistic regression was used to estimate the relative risk of breast cancer associated with toenail selenium levels. Individual matching for residing area (ruralaurban) and age (within AE 5 y) were used to avoid skewed distributions of these variables in the cases and the controls. Since this matching, however, was quite permissive, group matching was used in the analyses. The concentration of toenail selenium was log e -transformed to improve normality and categorized into quintiles by menopausal status. The use of vitamin supplements was only log-transformed, when antioxidant intakes were also energy-adjusted by the residual method. The background variables used in the logistic regression models were age, area, age at menarche, age at ®rst full-term pregnancy, use of oral contraceptives, use of estrogen replacement therapy, ®rst-degree family history of breast cancer, history of benign breast disease, level of education, current alcohol intake, smoking habits, leisure time activity, BMI, WHR and Toenail selenium and breast cancer S Ma Ènnisto È et al recruitment year. The recruitment year was used because more than one control was taken for each case in the early phase of the study, and because the selenium intake has changed annually in Finland since the beginning of selenium supplementation of fertilizers.
Results
The trend of toenail selenium concentration is shown by study years in Figure 1 . The selenium supplementation of fertilizers increased the selenium status of the whole population after 1984, reaching its peak in 1990. After that the monitoring group decided to lower the selenium supplementation level. The decreasing trend of toenail selenium concentration was also clearly seen in this study.
The mean toenail selenium concentrations were slightly lower (4 ± 5%) in cases than in controls, both in premenopausal and postmenopausal women, but the differences were not statistically signi®cant (Table 1) . Postmenopausal cases had signi®cantly higher retinol and vitamin C intakes (including supplements) compared to controls (P 0.01 and P 0.02, respectively), whereas no differences with respect to the antioxidant intakes were found between the premenopausal cases and controls. Of all premenopausal subjects, 9% used retinol supplements, 4% beta-carotene supplements, 17% vitamin C supplements and about 10% used selenium or vitamin E supplements regularly. Regular supplement use was quite similar in postmenopausal women.
The odds ratios for breast cancer by quintiles of toenail selenium and according to menopausal status are presented in Table 2 . The risk of premenopausal breast cancer decreased with rising toenail selenium concentration in the model adjusted for age and area, but in the multivariate models the association disappeared. In postmenopausal women, the multivariate odds ratios of toenail selenium were below unity in all three upper quintiles but the ®ndings were not statistically signi®cant. The intake of retinol, beta-carotene, vitamin E and vitamin C did not change the association between toenail selenium and breast cancer risk.
Discussion
Many geographical and animal studies have found that the de®ciency of dietary selenium may be related inversely to mortality and incidence of cardiovascular diseases and cancer. The ®ndings have been especially pronounced for breast and colon cancer (Schrauzer et al, 1977; Willett et al, 1991) . The most interesting human studies are from geographical areas where populations have a remarkably high or low selenium status. For example, in the United States, there are areas where selenium exposure from food is excessive. No reduced risk of breast, colon or rectum cancer, however, was found in men and women with high toenail selenium concentrations residing in South Dakota, but an inverse association was found for lung cancer in men (Poole, 1989) . In the northwestern state of Washington, the result of a nested case-control study did not support the association between selenium and the risk of cancer of all sites combined, in either men or women (Coates et al, 1988) . The same applies to a cohort of 4419 individuals from northern Italy, where unusually high selenium content was accidentally supplied in tap water (Vinceti et al, 1995) . It has been argued that selenium may be a protective factor for cancer only in low selenium areas because glutathione peroxidase reaches its maximal activity in plasma, red blood cells and platelets when the selenium intake exceeds 100 mgad (Alfthan et al, 1991) . For example, the selenium intake in the United States varies between 60 mg and 150 mgad (Garland et al, 1995) , and thus the glutathione peroxidase enzyme is probably saturated in a large part of the population.
Northern and eastern Europe, New Zealand, some parts of the United States and China are known as low-selenium areas (Alfthan & Neve, 1996) . In Finland, were many of the low selenium epidemiological studies have been carried out, low serum selenium (`45 mgal) has been associated Toenail selenium and breast cancer S Ma Ènnisto È et al with an increased risk of cancer in a cohort study (Salonen et al, 1985) . No statistically signi®cant associations were observed between low serum selenium and risk of different types of cancers, including breast cancer, in women in another cohort study (Knekt et al, 1990) . A recent doubleblind, placebo-controlled cancer prevention trial was carried out in a selenium-poor area in the eastern United States (Clark et al, 1996) . In all, 1312 subjects with a history of skin carcinoma were supplemented daily with oral administration of 200 mg selenium-enriched yeast or placebo for an average of 4.5 y. The primary end points of this trial were basal cell carcinoma and squamous cell carcinoma, but secondary end points were also assessed, that is, total mortality, cancer mortality, total cancer incidence, and the incidences of lung, prostate, and colorectal cancer. The average plasma selenium concentration increased during the treatment from 114 to 190 mgal. Selenium treatment had no effect on the incidence of skin cancers. Signi®cant reductions were found, however, in total cancer mortality, total cancer incidence, and the incidence of lung, colorectal and prostate cancers. New independent trials for the secondary end points are needed to con®rm these results.
The results of studies on selenium and breast cancer are inconclusive due to methodological limitations. For example, the studies in the 1980s had mainly small numbers of cases and used serum selenium, which re¯ects only shortterm selenium intake (Willett et al, 1991) . More recently published studies are listed in Table 3 . No association Table 2 Odds ratios and 95% con®dence intervals for premenopausal and postmenopausal breast cancer by quintiles of toenail selenium OR and 95% CI were estimated from multiple-logistic-regression equations, including terms of age, area, age at menarche, age at ®rst full-term pregnancy, use of oral contraceptives, use of estrogen replacement therapy, ®rst-degree family history of breast cancer, history of benign breast disease, level of education, current alcohol intake, smoking habits, leisure time activity, body mass index, waist-to-hip ratio and year of recruitment.
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OR and 95% CI were estimated from multiple-logistic-regression equations, including terms for age, area, age at menarche, age at ®rst full-term pregnancy, use of oral contraceptives, use of estrogen replacement therapy, ®rst-degree family history of breast cancer, history of benign breast disease, level of education, current alcohol intake, smoking habits, leisure time activity, body mass index, waist-to-hip ratio, year of recruitment, intakes of retinol, beta-carotene, vitamin E and vitamin C. between toenail selenium and breast cancer was found in the three largest studies: a cohort in the United States (Hunter et al, 1990) , a cohort in the Netherlands (van den Brandt et al, 1994) , and a case-control study of ®ve European countries (van't Veer et al, 1996) . Our study also showed that toenail selenium concentration was not associated with the decreased risk of breast cancer.
Two types of interactions between selenium and other nutrients with antioxidant properties have been reported earlier. In some studies, the protective effect of selenium has been stronger in subjects with a low intake of antioxidants such as vitamin A and E (Kok et al, 1987) or betacarotene (van den Brandt et al, 1994) . Other studies have shown the highest protective effects when the intakes of both selenium and antioxidants, such as alpha-tocopherol and beta-carotene, are high (Knekt et al, 1990) . Subjects with both low selenium and low alpha-tocopherol concentrations in serum had an 11-fold adjusted risk of death from cancer in a Finnish prospective study (Salonen et al, 1985) . In a trial conducted in China, subjects whose diets were supplemented daily with a combination of selenium, betacarotene and alpha-tocopherol had the lowest mortality of cancer (Blot et al, 1993) . In a case-control study of ®ve European countries, where the average antioxidant intake is higher than in China, no association was found between breast cancer and toenail selenium, beta-carotene or alphatocopherol in adipose tissue (van't Veer et al, 1996) . Similarly, no interaction between toenail selenium and antioxidant intakes from food was found in our study, where the selenium intake was adequate compared to the recommended level of 55 mgad for women (National Research Council, 1989 ).
An important question, raised from Finnish selenium studies carried out after 1984, is whether the supplementation of agricultural fertilizers with selenium has changed the ranking of subjects for their selenium intake. This question has been examined in the Alpha-Tocopherol Beta-Carotene Cancer Prevention Trial with 29 000 men (Hartman et al, 1998) . In that study, the same data was analyzed by using two different food composition databases, one based on the 1986 selenium database and the second based on the pre-supplementation time. The correlation between the calculated selenium intakes based on these two databases was 0.83. Based on this, the ranking of the men for their selenium intake seemed to hold both before and after the selenium supplementation of fertilizers.
Another important question is the time of toenail collection between the cases and the respective controls. A randomly selected population control was immediately drawn from the National Population Register when the breast cancer was diagnosed. The time period between the interview of a case and the control was usually from one to two months. Only in few exceptions the period was longer, but not more than one year. Consequently, the time of recruitment was controlled in the analyses. It should also be recognized that the higher non-response rate among the controls leaves open the possibility that the results may be somewhat biased. It is possible that women with healthier lifestyles are more likely to volunteer to epidemiological studies.
In conclusion, we found no evidence on an association between toenail selenium concentration and the risk of breast cancer in a population whose average selenium intake is at the recommended level as a result of the selenium supplementation of fertilizers. There was also no interaction between selenium and other antioxidants.
